Re­gen­eron's Schleifer, Yan­copou­los set their com­pa­ny's am­bi­tions sky high with $1.4B on the ta­ble in per­for­mance awards

One of the true suc­cess sto­ries in bio­phar­ma, New York’s Re­gen­eron has built a $51 bil­lion mar­ket cap un­der the watch­ful eyes of co-founders and 32-year vet­er­ans Len Schleifer and George Yan­copou­los. That suc­cess has made both men wealthy, even as Re­gen­eron’s in­vestor re­turns have flagged in re­cent years.

Re­gen­eron’s am­bi­tions are still sky high mov­ing ahead — and just how much the com­pa­ny can cap­i­tal­ize on that vi­sion could spell enor­mous pay­days for its founders.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER